Nevro Corp (NVRO)
3.49
-0.10
(-2.79%)
USD |
NYSE |
Jan 08, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
Nevro SG&A Expense (Quarterly): 68.47M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Inspire Medical Systems Inc | 130.39M |
| Inari Medical Inc | 108.27M |
| Stereotaxis Inc | 7.99M |
| Electromed Inc | 9.387M |
| Myomo Inc | 6.654M |